Diabetes Board decisions

The Board denied the veteran's claims for service connection and an earlier effective date, as well as a compensable rating for hearing loss.

The Board remands the claims for service connection for diabetes mellitus, heart disease, cervical spine disorder, and lumbar spine disorder due to a lack of compliance with prior remand directives.

The Board remands the claims for service connection for diabetes and right shoulder disability due to insufficient evidence.

The Veteran's service-connected retinopathy was granted an earlier effective date of May 1, 2022, for the increased disabling rating of 60 percent.

The Board granted service connection for ischemic heart disease, diabetes mellitus, and diabetic peripheral neuropathy based on presumed exposure to herbicide agents during the Veteran's service in or near the Korean DMZ.

The Board remands the claims for service connection of various conditions due to insufficient development and failure to properly address toxic exposures in service.

The appeal for service connection for hypertension and asthma was dismissed due to a timely notice of disagreement not being filed within one year of the rating decision. The claims for diabetes mellitus, type II and glaucoma were remanded for further development.

The Board remands the claims for service connection for stomach cancer, diabetes mellitus, glaucoma, and peripheral neuropathy of both upper and lower extremities to correct duty-to-assist errors related to potential exposure to hazardous chemicals and herbicides during the Veteran's service.

The Board denied an initial rating in excess of 20 percent for diabetes mellitus type II with erectile dysfunction, granted a separate initial rating of 10 percent for diabetic dermopathy, and granted a separate initial rating of 30 percent for chronic kidney disease. The higher initial rating for bilateral hearing loss was also denied.

The Board denied a rating greater than 40 percent for the Veteran's back condition and remanded claims for service connection for peptic ulcer disease, diabetes mellitus, diverticulitis, coronary artery disease, and myocardial infarction.

The Veteran is granted a total disability rating based on individual unemployability (TDIU) effective from March 14, 2014. The initial rating for diabetes mellitus type II and the left shoulder condition are denied or partially granted with specific ratings.

The Board remands the claims for service connection for diabetes mellitus, colon cancer, and neuropathy of the bilateral lower extremities due to further development needed.

The Board denied service connection for a pulmonary disability, to include sarcoidosis and emphysema, and diabetes mellitus as the evidence did not support a finding of an in-service injury or disease that was related to the current disabilities.

The Board remands the claim for service connection for diabetes mellitus, type II to prepare a TERA memorandum to assess whether the Veteran participated in toxic exposure risk activity during active service.

The Board remands the claim for service connection of diabetes mellitus type II to obtain an opinion on whether the Veteran's obesity, which may be related to his service-connected disabilities, is a substantial factor in causing his diabetes and whether it was aggravated by those conditions.

The veteran withdrew his appeal for all service connection and rating issues related to GERD, ischemic heart disease, hypertension, diabetes mellitus, TDIU, and DEA.

The Board granted service connection for diabetes mellitus type 2 due to herbicide exposure and peripheral neuropathy of the upper extremities secondary to the service-connected diabetes, but remanded the claim for cause of death.

The Board granted an earlier effective date of January 22, 2020, for the award of service connection for diabetic neurogenic bladder.

The Board denied an evaluation in excess of 60 percent for diabetic nephropathy with a left kidney mass, as the Veteran did not meet the criteria for a higher rating.

The Board remands the claims for a disability rating in excess of 20 percent for diabetes mellitus, type II and in excess of 10 percent for left lower extremity diabetic peripheral neuropathy to correct pre-decisional errors related to obtaining private treatment records.